Infection & chemotherapy · 2026
Incidence and Risk Factors for Recurrence of NDM- and KPC-Producing Enterobacterales after Achieving Clearance: A Retrospective Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Park Jihye, Lim Young-Ju, Kim Ja Young, Park Soyeon, Kim Eun Ok, Chong Yong Pil, Jung Jiwon, Kim Sung-Han
Аннотация
BACKGROUND: We aimed to determine the incidence and risk factors of recurrence after clearance of carbapenemase-producing Enterobacterales (CPE). We also sought to investigate whether there were differences in recurrence according to carbapenemase type.
MATERIALS AND METHODS: We conducted a retrospective case-control study (From January 2022 to December 2023) at a tertiary referral hospital in Korea. Recurrence was defined as positive culture or PCR test results for CPE with the same genotype as the first CPE isolation within 1 year after clearance.
RESULTS: Among 1,503 patients with New Delhi metallo-β-lactamase (NDM)- or Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacterales in whom clearance status could be assessed, 569 (37.8%) achieved clearance. Clearance was observed in 349 of 749 patients (46.6%) with NDM-producing isolates and 220 of 754 patients (29.2%) with KPC-producing isolates (P<0.001). Recurrence occurred in 65/569 (11.4%) patients after clearance - 34/349 (9.7%) in NDM group and 31/220 (14.1%) in the KPC group (P=0.112). Multivariate analysis identified central venous catheter dwelling after clearance as an independent risk factors for CPE recurrence (adjusted odds ratio [aOR], 2.27; 95% confidence interval [CI], 1.16-4.43; P=0.016).
CONCLUSION: Recurrence occurred in approximately one out of ten patients after clearance within one year, and did not differ significantly by carbapenemase type. Post-clearance indwelling devices, particularly central venous catheters, were associated with recurrence, underscoring the need for targeted infection control strategies after documented clearance.
MATERIALS AND METHODS: We conducted a retrospective case-control study (From January 2022 to December 2023) at a tertiary referral hospital in Korea. Recurrence was defined as positive culture or PCR test results for CPE with the same genotype as the first CPE isolation within 1 year after clearance.
RESULTS: Among 1,503 patients with New Delhi metallo-β-lactamase (NDM)- or Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacterales in whom clearance status could be assessed, 569 (37.8%) achieved clearance. Clearance was observed in 349 of 749 patients (46.6%) with NDM-producing isolates and 220 of 754 patients (29.2%) with KPC-producing isolates (P<0.001). Recurrence occurred in 65/569 (11.4%) patients after clearance - 34/349 (9.7%) in NDM group and 31/220 (14.1%) in the KPC group (P=0.112). Multivariate analysis identified central venous catheter dwelling after clearance as an independent risk factors for CPE recurrence (adjusted odds ratio [aOR], 2.27; 95% confidence interval [CI], 1.16-4.43; P=0.016).
CONCLUSION: Recurrence occurred in approximately one out of ten patients after clearance within one year, and did not differ significantly by carbapenemase type. Post-clearance indwelling devices, particularly central venous catheters, were associated with recurrence, underscoring the need for targeted infection control strategies after documented clearance.